An atrial septal defect is an opening in the wall that separates the upper chambers of the heart. It is one of the most common congenital heart defects, which are structural problems that develop ...

Beijing Zhongke Journal Publising Co. Ltd. Congenital heart defects (CHDs) are the most common birth defects, occurring in approximately 0.9% of live births. Sadly, they are also the leading cause of ...

The AI model was more efficient at detecting signatures of atrial septal defect (ASD) in electrocardiograms (ECG) than traditional methods. Investigators from Brigham and Women's Hospital, a founding ...

When expectant parents imagine their baby’s beating heart, few consider the possibility of a structural issue being present from day one. Yet for thousands of families each year, this becomes reality ...

† Primum (2 patients), secundum (68 patients) and sinus defects (4 patients). § Surgical branch of the study. TEE = Transesophageal echocardiography. *Children and adults. † Percutaneous branch of the ...

BAAR, Switzerland and MOUNTAIN VIEW, Calif., July 14, 2021 /PRNewswire/ -- atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal ...

The AI model was more efficient at detecting signatures of atrial septal defect (ASD) in electrocardiograms (ECG) than traditional methods. Investigators from Brigham and Women’s Hospital, a founding ...

BAAR, Switzerland and SANTA CLARA, Calif., Feb. 8, 2022 /PRNewswire/ -- atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal ...

AtHeart Medical is moving on to the second phase of an IDE pivotal trial for its bioresorbable atrial septal defects occluder (ASD). The ASCENT ASD IDE trial is a 250- patient single-arm study that is ...

TCT 195: Percutaneous Patent Foramen Ovale Closure for Migraine with the Amplatzer PFO Occluder: A Pooled Analysis of Individual Participant Data from the Randomized Trials Receive the the latest news ...

Patients undergoing transcatheter atrial septal defect (ASD) closure did not have worsening migraines after completing a course of dual antiplatelet therapy, the CANOA investigators found. Overall, ...